Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J O Atiba

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 1, 1992
Too many physicians doing too much?J O Atiba
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Correction--malignant gliomaJ O Atiba, F L Meyskens
Seminars in Oncology|June 11, 1992
Chemoprevention of breast cancerJ O Atiba, F L Meyskens
Investigational New Drugs|January 1, 1996
A phase II trial of a differentiating agent (tRA) with cisplatin-VP 16 chemotherapy in advanced non-small cell lung cancerR Thiruvengadam, J O Atiba, S H Azawi
Tropical Doctor|October 1, 1985
Acute poisoning in the emergency room in Lagos University Teaching HospitalO L Tunwashe, O O Odukoya, J O Atiba
British Journal of Clinical Pharmacology|August 1, 1989
Effects of ketoconazole on the polymorphic 4-hydroxylations of S-mephenytoin and debrisoquineJ O Atiba, T F Blaschke, G R Wilkinson
British Journal of Clinical Pharmacology|June 1, 1987
Plasma antipyrine half-life can be determined from urine dataJ O Atiba, G Taylor, R A Pershe, et al.
Clinical Pediatrics|November 1, 1987
Rhabdomyolysis complicating doxylamine overdoseF S Mendoza, J O Atiba, A M Krensky, et al.
American Journal of Therapeutics|April 1, 1997
Restoration of oral all-trans retinoic acid bioavailability after a brief drug holidayJ O Atiba, A M Manzardo, R Thiruvengadam, et al.
Investigational New Drugs|January 1, 1994
Phase II evaluation of mitoxantrone plus cis-platinum in patients with advanced breast cancer. A Southwest Oncology Group studyJ O Atiba, S J Green, H E Hynes, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 1, 1992
Too many physicians doing too much?J O Atiba
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Correction--malignant gliomaJ O Atiba, F L Meyskens
Seminars in Oncology|June 11, 1992
Chemoprevention of breast cancerJ O Atiba, F L Meyskens
Investigational New Drugs|January 1, 1996
A phase II trial of a differentiating agent (tRA) with cisplatin-VP 16 chemotherapy in advanced non-small cell lung cancerR Thiruvengadam, J O Atiba, S H Azawi
Tropical Doctor|October 1, 1985
Acute poisoning in the emergency room in Lagos University Teaching HospitalO L Tunwashe, O O Odukoya, J O Atiba
British Journal of Clinical Pharmacology|August 1, 1989
Effects of ketoconazole on the polymorphic 4-hydroxylations of S-mephenytoin and debrisoquineJ O Atiba, T F Blaschke, G R Wilkinson
British Journal of Clinical Pharmacology|June 1, 1987
Plasma antipyrine half-life can be determined from urine dataJ O Atiba, G Taylor, R A Pershe, et al.
Clinical Pediatrics|November 1, 1987
Rhabdomyolysis complicating doxylamine overdoseF S Mendoza, J O Atiba, A M Krensky, et al.
American Journal of Therapeutics|April 1, 1997
Restoration of oral all-trans retinoic acid bioavailability after a brief drug holidayJ O Atiba, A M Manzardo, R Thiruvengadam, et al.
Investigational New Drugs|January 1, 1994
Phase II evaluation of mitoxantrone plus cis-platinum in patients with advanced breast cancer. A Southwest Oncology Group studyJ O Atiba, S J Green, H E Hynes, et al.
Pageof 2